Brainomix
Healthcare AI
AI medical imaging / stroke imaging / lung fibrosis
Series C
Brainomix is an Oxford University spinout that develops AI-powered medical imaging software for stroke and lung disease, with a focus on turning scans into validated imaging biomarkers to support faster diagnosis and treatment decisions. Its flagship Brainomix 360 Stroke platform is used in hospitals internationally and the company also offers AI solutions for pulmonary fibrosis and related life-science use cases.
Company Details
- Website
- brainomix.com
- Headquarters
- Oxford, England, United Kingdom
- Founded
- 2010
- Funding
- £21M+ disclosed (at least £7M + £14M; earlier funding not fully captured)
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring